Information Provided By:
Fly News Breaks for January 28, 2020
CNC
Jan 28, 2020 | 08:03 EDT
Bernstein analyst Lance Wilkes raised his price target for Centene to $103 from $84 to reflect accretion associated with the WellCare merger and underlying organic strength from Medicaid growth. Centene is the analyst's top pick with 52% potential upside. Wilkes highlights Centene's long-term growth of "high acuity" in Medicaid and Medicaid expansion, its potentially positive positioning for a Democratic sweep in 2020, and an attractive valuation. He maintains an Outperform rating on the shares.
News For CNC From the Last 2 Days
There are no results for your query CNC